Illumina | ILMN - Sales Revenues

Stock Price
141.46
Daily Change
-3.35 -2.31%
Monthly
0.09%
Yearly
7.90%
Q1 Forecast
140.35

Illumina reported $1.08B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Agilent USD 1.86B 123M Sep/2025
Bio Techne USD 286.56M 30.44M Sep/2025
Bio-Rad Laboratories USD 653M 1.4M Sep/2025
Boston Scientific USD 5.07B 10M Sep/2025
Bruker USD 860.5M 63.1M Sep/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Danaher USD 6.84B 790M Dec/2025
Dentsply International USD 904M 32M Sep/2025
Edwards Lifesciences USD 1.55B 20M Sep/2025
Exact Sciences USD 851M 39.9M Sep/2025
Hologic USD 1.05B 0 Dec/2025
Illumina USD 1.08B 20M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
IQVIA Holdings USD 4.1B 80M Sep/2025
Laboratory Of America USD 3.56B 30M Sep/2025
Mettler Toledo International USD 1.03B 46.78M Sep/2025
Myriad Genetics USD 205.7M 7.4M Sep/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
Quidel USD 700M 86M Sep/2025
Repligen USD 189M 7M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Standard Biotools USD 19.55M 2.21M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Waters USD 800M 29M Sep/2025